Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1742-4690
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Importance of Fc-mediated functions of anti-HIV-1 broadly neutralizing antibodies ; volume:15 ; number:1 ; day:22 ; month:8 ; year:2018 ; pages:1-12 ; date:12.2018
Retrovirology ; 15, Heft 1 (22.8.2018), 1-12, 12.2018
- Urheber
-
Parsons, Matthew S.
- Beteiligte Personen und Organisationen
-
Chung, Amy W.
Kent, Stephen J.
SpringerLink (Online service)
- DOI
-
10.1186/s12977-018-0438-x
- URN
-
urn:nbn:de:101:1-2018101620383905772482
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
- 15.08.2025, 07:21 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Parsons, Matthew S.
- Chung, Amy W.
- Kent, Stephen J.
- SpringerLink (Online service)
Ähnliche Objekte (12)
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Broadly Neutralizing Antibodies for HIV Eradication
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
Design clues from functional constraints and broadly neutralizing antibodies
S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Broadly Neutralizing Antibodies for HIV Eradication
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
Design clues from functional constraints and broadly neutralizing antibodies
S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1
Broadly neutralizing antibodies and vaccine design against HIV-1 infection
Development of an anti-HIV vaccine eliciting broadly neutralizing antibodies
Broadly Neutralizing Antibodies for HIV Eradication
SHIVs, monkeys, and anti-HIV-1 neutralizing antibodies
The expanding array of HIV broadly neutralizing antibodies
Autoreactivity profiles of influenza hemagglutinin broadly neutralizing antibodies
Administration of broadly neutralizing anti-HIV-1 antibodies at ART initiation maintains long-term CD8+ T cell immunity
Design clues from functional constraints and broadly neutralizing antibodies
S021-05 OA. Broadly neutralizing anti-HIV-1 antibodies disrupt a hinge-related function of gp41 at the membrane interface
Administration of anti-HIV-1 broadly neutralizing monoclonal antibodies with increased affinity to Fcγ receptors during acute SHIVAD8-EO infection
Identification and characterization of broadly neutralizing antibodies targeting viral infections
Ultrapotent Broadly Neutralizing Human‐llama Bispecific Antibodies against HIV‐1